Emerging roles of innate and adaptive immunity in Alzheimer's disease

X Chen, DM Holtzman - Immunity, 2022 - cell.com
Alzheimer's disease (AD) is the most common neurodegenerative disease, with
characteristic extracellular amyloid-β (Aβ) deposition and intracellular accumulation of …

Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities

G Hajishengallis, T Chavakis - Nature Reviews Immunology, 2021 - nature.com
Periodontitis, a major inflammatory disease of the oral mucosa, is epidemiologically
associated with other chronic inflammation-driven disorders, including cardio-metabolic …

Exercise plasma boosts memory and dampens brain inflammation via clusterin

Z De Miguel, N Khoury, MJ Betley, B Lehallier… - Nature, 2021 - nature.com
Physical exercise is generally beneficial to all aspects of human and animal health, slowing
cognitive ageing and neurodegeneration. The cognitive benefits of physical exercise are …

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases

R Fernández-Calle, SC Konings… - Molecular …, 2022 - Springer
ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human
polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of …

Neuroimmune cardiovascular interfaces control atherosclerosis

SK Mohanta, L Peng, Y Li, S Lu, T Sun, L Carnevale… - Nature, 2022 - nature.com
Atherosclerotic plaques develop in the inner intimal layer of arteries and can cause heart
attacks and strokes. As plaques lack innervation, the effects of neuronal control on …

[HTML][HTML] Spatial transcriptomics and in situ sequencing to study Alzheimer's disease

WT Chen, A Lu, K Craessaerts, B Pavie, CS Frigerio… - Cell, 2020 - cell.com
Although complex inflammatory-like alterations are observed around the amyloid plaques of
Alzheimer's disease (AD), little is known about the molecular changes and cellular …

[PDF][PDF] Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the …

J Boren, MJ Chapman, RM Krauss… - European heart …, 2020 - academic.oup.com
OP-EHEA191011_online 2313..2340 Page 1 Low-density lipoproteins cause atherosclerotic
cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus …

Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases

T Bartels, S De Schepper, S Hong - Science, 2020 - science.org
Dementia is a rapidly rising global health crisis that silently disables families and ends lives
and livelihoods around the world. To date, however, no early biomarkers or effective …

The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration

J Zhou, SD Wade, D Graykowski, MF Xiao… - Science translational …, 2023 - science.org
Complement overactivation mediates microglial synapse elimination in neurological
diseases such as Alzheimer's disease (AD) and frontotemporal dementia (FTD), but how …

TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration

L Zhong, X Sheng, W Wang, Y Li, R Zhuo, K Wang… - Immunity, 2023 - cell.com
Triggering receptor expressed on myeloid cells 2 (TREM2) is strongly linked to Alzheimer's
disease (AD) risk, but its functions are not fully understood. Here, we found that TREM2 …